Skip to content
UniqueCapital

UNIQUE RESEARCH / ENGLISH ARTICLE

Medical Product Marketing Firm Yidiantong Receives Equity from Kaixian Capital

Unique Research · Company / Funding · July 4, 2022

On Jun 28, 2022, medical product marketing firm Yidiantong (医点通) (founded 2015) received equity from Kaixian Capital — 4th round — for academic-event promotion and platform upgrades. Digital marketing for pharma/device firms; international clinician advisors; dual-track localization of global medtech. Affiliated VC Xinzhaoyuan incubates early life-science; focus cardio/neuro, oncology, AI, medical robotics. Smart medical-conference platform; hundreds of events/year; >1M doctor + 500k pharma-staff tagged DB. Controller Wen Yaxin 54.8%.

— END —

Editorial English edition by Unique Research, published on UniqueCapital on July 4, 2022. This translation is based on an earlier Chinese article; the Chinese source is credited separately and is not treated as a line-by-line mirror.

View the Chinese source article ↗
← Back to English research